Physician profile
Bhavya Kumar
NPI 1578977922
$442.26
in general payments reported to CMS, 2019-2025
11 companies · $253 in 2025
The $253 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $25.10 · 2023: $45.63 · 2024: $119 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $417.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $106.41 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Teva Pharmaceuticals USA, INC. | $87.47 | 2024-2025 | Austedo Xr, Austedo Xr, Uzedy |
| Novo Nordisk INC | $47.80 | 2024-2025 | Rybelsus, Ozempic |
| Neurocrine Biosciences, INC. | $35.89 | 2025 | |
| Pfizer INC. | $31.02 | 2025 | |
| Novartis Pharmaceuticals Corporation | $28.77 | 2023 | |
| Hologic Sales and Service, LLC | $25.81 | 2024 | Thinprep 2000 Processor, Aptima |
| Alexion Pharmaceuticals, INC. | $25.10 | 2022 | |
| Lilly USA, LLC | $22.05 | 2025 | Zepbound |
| Sumitomo Pharma America, INC. | $16.86 | 2023 | Gemtesa |
| Abbvie INC. | $15.08 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bhavya Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.